SiNtx Technologies, Inc. Common Stock (SINT) Stock Price

SINTStock

$1.74−57.25%52W

Market Cap$13.15M

P/E—

PEG Ratio—

Div yield—

Beta0.58

SINT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-47.76%

Price vs S&P 500 (4W)0.19%

VGM Score39.95

Book Value / Share (Quarterly)$0.73

P/TBV (Annual)5.33x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-13.28%

Cash Flow / Share (Quarterly)$-1.56

Price vs S&P 500 (YTD)-66.85%

Gross Margin (TTM)52.86%

Net Profit Margin (TTM)-848.20%

EPS (TTM)$-3.03

10-Day Avg Trading Volume0.06M

EPS Excl Extra (TTM)$-3.03

Revenue Growth (5Y)11.38%

EPS (Annual)$-3.74

ROI (Annual)-353.00%

Gross Margin (Annual)45.28%

Net Profit Margin (5Y Avg)-804.34%

Cash / Share (Quarterly)$0.54

Revenue Growth QoQ (YoY)199.34%

ROA (Last FY)-109.03%

Revenue Growth TTM (YoY)-28.53%

EBITD / Share (TTM)$-2.93

ROE (5Y Avg)-199.26%

Operating Margin (TTM)-884.81%

Cash Flow / Share (Annual)$-2.21

P/B Ratio2.72x

P/B Ratio (Quarterly)1.67x

Net Income / Employee (Annual)$-323,900

EV / Revenue (TTM)7.27x

Net Interest Coverage (TTM)-10363.00x

ROA (TTM)-115.37%

EPS Incl Extra (Annual)$-3.74

Current Ratio (Annual)1.51x

Quick Ratio (Quarterly)1.32x

3-Month Avg Trading Volume0.09M

52-Week Price Return-57.25%

Revenue / Employee (TTM)$41,600

Tangible BV / Share (Quarterly)$0.71

P/S Ratio (Annual)12.92x

Asset Turnover (Annual)0.11x

52-Week High$4.50

Operating Margin (5Y Avg)-892.46%

EPS Excl Extra (Annual)$-3.74

CapEx CAGR (5Y)-12.09%

Tangible BV CAGR (5Y)-35.91%

26-Week Price Return-37.86%

Quick Ratio (Annual)1.16x

13-Week Price Return9.43%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)2.36x

Enterprise Value$9.66M

Revenue / Share Growth (5Y)-77.19%

Asset Turnover (TTM)0.14x

Book Value / Share Growth (5Y)-87.66%

Revenue / Employee (Annual)$31,800

Inventory Turnover (Annual)0.84x

Pretax Margin (Annual)-1018.07%

Cash / Share (Annual)$1.04

3-Month Return Std Dev72.11%

Gross Margin (5Y Avg)59.26%

Net Income / Employee (TTM)$-352,500

ROE (Last FY)-353.84%

Net Interest Coverage (Annual)-29.66x

EPS Basic Excl Extra (Annual)$-3.74

Receivables Turnover (TTM)6.24x

Total Debt / Equity (Quarterly)0.02x

EPS Incl Extra (TTM)$-3.03

Receivables Turnover (Annual)5.44x

ROI (TTM)-346.97%

P/S Ratio (TTM)9.89x

Pretax Margin (5Y Avg)-804.34%

Revenue / Share (Annual)$0.37

Tangible BV / Share (Annual)$0.70

Price vs S&P 500 (52W)-72.78%

Year-to-Date Return-54.92%

5-Day Price Return-18.31%

EPS Normalized (Annual)$-3.74

ROA (5Y Avg)-79.77%

Net Profit Margin (Annual)-1018.07%

Month-to-Date Return-21.97%

Cash Flow / Share (TTM)$-4.95

EBITD / Share (Annual)$-3.75

Operating Margin (Annual)-1053.14%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-194.64%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-3.03

P/TBV (Quarterly)1.72x

P/B Ratio (Annual)5.08x

Inventory Turnover (TTM)0.48x

Pretax Margin (TTM)-848.20%

Book Value / Share (Annual)$0.74

Price vs S&P 500 (13W)6.75%

Beta0.58x

Revenue / Share (TTM)$0.27

ROE (TTM)-354.44%

52-Week Low$1.40

vGradeD

gGradeC

mGradeD

vgmGradeD

SINT Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 11, 2026	-$0.73	-$0.75	-2.74%(-$0.02)
Q1 2026	May 15, 2026	-$0.66	-$0.70	-6.06%(-$0.04)
Q3 2025	Nov 12, 2025	-$0.55	-$3.46	-529.09%(-$2.91)
Q2 2025	Aug 14, 2025	-$0.79	-$1.05	-33.32%(-$0.26)

SINT Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.13

4.11

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
SINTSiNtx Technologies, Inc. Common Stock	D	C	D	9.9x	11.4%	52.9%	-884.8%	$1.74
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About SiNtx Technologies, Inc. Common Stock

SINTX Technologies Inc manufactures silicon nitride ceramics for biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, and antipathogenic with strong bone affinity characteristics. The company's silicon nitride spinal implants have achieved clinical adoption in the US, Europe, Brazil, and Taiwan.